The test is designed to stratify patients diagnosed with pancreatic cystic lesions based on their risk of developing pancreatic cancer.

The approval enables Trinity to transition upstream production from in-house operations to an outsourced model.

The firm's Clinical Viewer is cleared for use with the Hamamatsu NanoZoomer S360MD Slide scanner, NDPI image formats, and the Barco NV MDPC-8127 display.